Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. 1993

J Blasi, and E R Chapman, and S Yamasaki, and T Binz, and H Niemann, and R Jahn
Howard Hughes Medical Institute, Yale University Medical School, New Haven, CT 06510.

The anaerobic bacterium Clostridium botulinum produces several related neurotoxins that block exocytosis of synaptic vesicles in nerve terminals and that are responsible for the clinical manifestations of botulism. Recently, it was reported that botulinum neurotoxin type B as well as tetanus toxin act as zinc-dependent proteases that specifically cleave synaptobrevin, a membrane protein of synaptic vesicles (Link et al., Biochem. Biophys. Res. Commun., 189, 1017-1023; Schiavo et al., Nature, 359, 832-835). Here we report that inhibition of neurotransmitter release by botulinum neurotoxin type C1 was associated with the proteolysis of HPC-1 (= syntaxin), a membrane protein present in axonal and synaptic membranes. Breakdown of HPC-1/syntaxin was selective since no other protein degradation was detectable. In vitro studies showed that the breakdown was due to a direct interaction between HPC-1/syntaxin and the toxin light chain which acts as a metallo-endoprotease. Toxin-induced cleavage resulted in the generation of a soluble fragment of HPC-1/syntaxin that is 2-4 kDa smaller than the native protein. When HPC-1/syntaxin was translated in vitro, cleavage occurred only when translation was performed in the presence of microsomes, although a full-length product was obtained in the absence of membranes. However, susceptibility to toxin cleavage was restored when the product of membrane-free translation was subsequently incorporated into artificial proteoliposomes. In addition, a translated form of HPC-1/syntaxin, which lacked the putative transmembrane domain at the C-terminus, was soluble and resistant to toxin action. We conclude that HPC-1/syntaxin is involved in exocytotic membrane fusion.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D001905 Botulinum Toxins Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS. Botulin,Botulinum Neurotoxin,Botulinum Neurotoxins,Clostridium botulinum Toxins,Botulinum Toxin,Neurotoxin, Botulinum,Neurotoxins, Botulinum,Toxin, Botulinum,Toxins, Botulinum,Toxins, Clostridium botulinum
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D013570 Synaptic Membranes Cell membranes associated with synapses. Both presynaptic and postsynaptic membranes are included along with their integral or tightly associated specializations for the release or reception of transmitters. Membrane, Synaptic,Membranes, Synaptic,Synaptic Membrane
D050827 Syntaxin 1 A neuronal cell membrane protein that combines with SNAP-25 and SYNAPTOBREVIN 2 to form a SNARE complex that leads to EXOCYTOSIS. HPC-1 Protein,Neuronal Cell Membrane Antigen, HPC-1,P35B Antigen,Syntaxin 1 Protein,Syntaxin 1A,Syntaxin A,Syntaxin A Protein,Syntaxin-1A,Syntaxin-1A Protein,Syntaxin-1B,Syntaxin-1B Protein,Syntaxin-1C,Syntaxin-1C Protein,Syntaxin-2,Syntaxin-2 Protein,p35b Protein,HPC 1 Protein,Neuronal Cell Membrane Antigen, HPC 1,Syntaxin 1A Protein,Syntaxin 1B,Syntaxin 1B Protein,Syntaxin 1C,Syntaxin 1C Protein,Syntaxin 2,Syntaxin 2 Protein
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

J Blasi, and E R Chapman, and S Yamasaki, and T Binz, and H Niemann, and R Jahn
April 1995, Neuroscience,
J Blasi, and E R Chapman, and S Yamasaki, and T Binz, and H Niemann, and R Jahn
January 2017, Autophagy,
J Blasi, and E R Chapman, and S Yamasaki, and T Binz, and H Niemann, and R Jahn
June 2001, Biochimica et biophysica acta,
J Blasi, and E R Chapman, and S Yamasaki, and T Binz, and H Niemann, and R Jahn
September 2002, Neuroscience letters,
J Blasi, and E R Chapman, and S Yamasaki, and T Binz, and H Niemann, and R Jahn
December 1997, Proceedings of the National Academy of Sciences of the United States of America,
J Blasi, and E R Chapman, and S Yamasaki, and T Binz, and H Niemann, and R Jahn
February 1996, Biochemistry,
J Blasi, and E R Chapman, and S Yamasaki, and T Binz, and H Niemann, and R Jahn
July 1995, Biochemical and biophysical research communications,
J Blasi, and E R Chapman, and S Yamasaki, and T Binz, and H Niemann, and R Jahn
August 1990, Nucleic acids research,
J Blasi, and E R Chapman, and S Yamasaki, and T Binz, and H Niemann, and R Jahn
July 1995, The Journal of biological chemistry,
J Blasi, and E R Chapman, and S Yamasaki, and T Binz, and H Niemann, and R Jahn
October 1997, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!